Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
about
Comparative safety of serotonin (5-HT3) receptor antagonists in patients undergoing surgery: a systematic review and network meta-analysisTreatment of established postoperative nausea and vomiting: a quantitative systematic reviewDolasetron decreases postoperative nausea and vomiting after breast surgery.
P2860
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@en
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@nl
type
label
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@en
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@nl
prefLabel
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@en
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@nl
P2093
P2860
P356
P1476
Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting.
@en
P2093
Bradburn BG
D'Hollander A
Diemunsch P
Panouillot P
P2860
P2888
P304
P356
10.1007/BF03013007
P577
1997-02-01T00:00:00Z